In the context of demyelinating disease, APCDD1 is increased in endothelial cells in mice with experimental autoimmune encephalitis, and APCDD1 protein and APCDD1 mRNA are increased in human multiple sclerosis (MS) lesions (18, 24). This evidence concerns the gene APCDD1 and myeloid sarcoma.